Viewing Study NCT03108495

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:16 PM
Ignite Modification Date: 2026-02-21 @ 11:35 PM
Study NCT ID: NCT03108495
Status: TERMINATED
Last Update Posted: 2025-09-17
First Post: 2017-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma
Sponsor: Iovance Biotherapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LN-145 View
None Cell Therapy View
None Autologous Adoptive Cell Transfer View
None Autologous Adoptive Cell Therapy View
None Cellular Immuno-therapy View
None Tumor Infiltrating Lymphocytes View
None TIL View
None IL-2 View
None Pembrolizumab View